Ainos (AIMD) Total Debt to Capital

AIMD (ainos.com) - company brandmark

The price trend illustrated in this chart demonstrates the debt load of Ainos, Inc. (AIMD), which stands at 4.54. Ainos, Inc. (AIMD) is implementing eco-solutions, replacing center visits with home screening to reduce emissions. The business relies on the development of B2B tools for detecting oncology and lung pathologies. Meanwhile, management of the Taiwanese enterprise is currently scaling the distribution of AI systems, facing moderate risks.

AIMD: ainos.com Debt to Equity Ratio 04/28/2023 - 10/31/2026

Analytical breakdowns for Ainos Corporation (AIMD)

- price and consensus price forecast:
Price Chart Ainos|AIMD - Consensus Target
- market capitalization details:
Market Capitalization Ainos|AIMD - Total Enterprise Value
- book capitalization indicators:
Book Value per Share Ainos|AIMD - Accounting Capitalization|Market Capitalization to Book Value Ratio ainos.com|AIMD - Company Total Assets
- issuer credit burden and liquidity indicators:
Debt to Equity Ainos, Inc.|AIMD - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Ainos, Inc.|AIMD - Company Aggregate Debts|Debt to Book Capitalization Ratio Ainos|AIMD - Company Long-Term Debt|Company Current Liabilities Ainos|Quick Liquidity ainos.com
- earnings and valuation multiples information:
AIMD - Net Financial Result
Basic company analysis:AIMD, Ainos
Core merchandise of Ainos Corporation

Scaling the analyzer network of Ainos, Inc. (AIMD) requires capital expenditures that can be financed through debt or equity. This indicator measures the proportion of all liabilities within the financing structure, allowing for an assessment of the business's dependence on creditors via financial leverage—specifically the debt-to-equity ratio—to determine solvency risks.

Key competitors

Debt to Equity Agilent|Total Debt to Equity Ratio Quest Diagnostics Inc. (DGX)|Total Debt to Capital ILMN|EXAS - Debt to Capital|Total Debt to Capital RVTY (Revvity, Inc.)|BIO: Debt to Equity Ratio|Anbio - Total Debt to Capital|SHC - Total Debt to Capital|QuidelOrtho Corp (QDEL) - Debt to Equity|Debt to Equity Ratio OPK|CDNA (CareDx Inc) - Total Debt to Capital|Total Debt to Capital maravai.com|Debt to Equity Fulgent Genetics (FLGT)|Debt to Equity LAB (Standard BioTools Inc)|Cytek Bio - Total Debt to Equity Ratio|OraSure Corp (OSUR) - Debt to Capital|XGN - Debt to Equity|Total Debt to Capital Coefficient mdxhealth.com MDXH|LUCD: Total Debt to Capital|PRE - Total Debt to Capital Coefficient|Debt to Equity Insight Molecular Diagnostics, Inc.|Trinity Biotech Corp (TRIB) - Total Debt to Capital Coefficient|Total Debt to Capital PRPH|Total Debt to Capital codiagnostics.com (CODX)|Total Debt to Capital HSCS (HeartSciences)|Total Debt to Capital Coefficient Biomerica Inc. (BMRA)|CDIO - Debt to Equity|VRAX (Virax Biolabs Corp) - Debt to Equity Ratio|Bluejay Diagnostics (BJDX) - Debt to Equity|Debt to Capital aspirawh.com (AWH)|Debt to Equity Accelerate Diagnostics, Inc.|Centogene NV (CNTG) - Total Debt to Capital Coefficient|Total Debt to Equity Ratio ENZ (Enzo Biochem, Inc.)|FRES (fresh2.co) - All Debt to Shareholders' Equity Ratio|Total Debt to Capital GENE (Genetic Technologies Limited)|Total Debt to Capital Coefficient 23andme.com (ME)|PMD - Debt to Equity